Publication | Open Access

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

VaccinationReceptor Binding DomainCross-protectionVaccine DevelopmentImmunologyNanoparticle VaccinesTherapeutic VaccineVaccine DesignMedicineViral ImmunityHeptad Repeat